Astrazeneca Pharma India Live BSE/NSE | Astrazeneca Pharma India Fundamenta data | Astrazeneca Pharma India Balance sheet | Astrazeneca Pharma India Quarterly Results | Astrazeneca Pharma India Profit & Loss | Astrazeneca Pharma India Financial Ratios

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,403.88
92.06
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,277.95
N/A
15.05

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
3.80
0.43

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
23.03

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
70.15

P:E (Median)

8 Years
5 Years
3 Years

52.70
94.33
124.61

P:BV (Average)

8 Years
5 Years
3 Years

17.75
16.08
14.54

EV:EBITDA (Average)

8 Years
5 Years
3 Years

41.27
52.66
63.38

Quarterly Results

Standalone Figures in Rs. Crores

Description Dec 18 Dec 17 Var% Sep 18 Sep 17 Var% Jun 18 Jun 17 Var% Mar 18 Mar 17 Var%
Net Sales 215.19 128.54 67.41% 161.36 164.26 -1.77% 161.44 128.47 25.66% 150.73 116.88 28.96%
Expenses 174.31 139.38 25.06% 146.60 128.61 13.99% 152.16 122.25 24.47% 135.46 116.19 16.58%
EBITDA 40.88 -10.85 - 14.76 35.65 -58.60% 9.28 6.22 49.20% 15.27 0.69 2,113.04%
EBIDTM 19.00% -8.44% 9.15% 21.70% 5.75% 4.84% 10.13% 0.59%
Other Income 3.50 2.76 26.81% 3.35 2.50 34.00% 3.42 4.65 -26.45% 2.34 0.99 136.36%
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 3.78 3.73 1.34% 3.67 3.75 -2.13% 3.55 3.71 -4.31% 3.55 3.67 -3.27%
PBT 40.59 -11.82 - 14.44 34.40 -58.02% 9.15 7.16 27.79% 14.06 -1.99 -
Tax 11.50 -1.46 - 5.31 7.01 -24.25% 2.76 1.37 101.46% 10.84 7.57 43.20%
PAT 29.09 -10.35 - 9.13 27.39 -66.67% 6.39 5.80 10.17% 3.22 -9.56 -
PATM 13.52% -8.05% 5.66% 16.67% 3.96% 4.51% 2.14% -8.18%
EPS 11.64 -4.14 - 3.65 10.95 -66.67% 2.56 2.32 10.34% 1.29 -3.82 -

Description Sep 18 Sep 17 Var% Jun 18 Jun 17 Var% Mar 18 Mar 17 Var% Dec 17 Dec 16 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Dec 09 Dec 08
Net Sales 688.72 571.00 543.71 563.73 517.07 473.97 390.42 530.82 593.52 396.69 353.63 Net Sales Growth 27.98% 5.02% -3.55% 9.02% 9.09% 21.40% -26.45% -10.56% 49.62% 12.18% Cost Of Goods Sold 215.05 178.78 171.18 194.81 194.23 155.08 146.54 162.20 159.00 107.77 84.87 Gross Profit 473.67 392.22 372.53 368.93 322.84 318.90 243.88 368.63 434.52 288.92 268.76 GP Margin 68.78% 68.69% 68.52% 65.44% 62.44% 67.28% 62.47% 69.45% 73.21% 72.83% 76.00% Total Expenditure 608.53 524.71 506.77 547.31 528.48 486.94 458.88 500.56 489.76 307.64 241.39 Power & Fuel Cost - 8.30 7.68 7.43 8.51 8.69 5.82 3.10 3.31 1.96 2.25 % Of Sales - 1.45% 1.41% 1.32% 1.65% 1.83% 1.49% 0.58% 0.56% 0.49% 0.64% Employee Cost - 153.53 162.04 169.35 159.84 160.46 148.46 161.91 150.50 81.33 60.80 % Of Sales - 26.89% 29.80% 30.04% 30.91% 33.85% 38.03% 30.50% 25.36% 20.50% 17.19% Manufacturing Exp. - 50.10 36.40 25.82 17.69 35.93 38.26 38.29 29.68 26.91 33.46 % Of Sales - 8.77% 6.69% 4.58% 3.42% 7.58% 9.80% 7.21% 5.00% 6.78% 9.46% General & Admin Exp. - 43.35 55.04 59.10 63.77 66.68 63.95 94.63 88.87 55.55 33.57 % Of Sales - 7.59% 10.12% 10.48% 12.33% 14.07% 16.38% 17.83% 14.97% 14.00% 9.49% Selling & Distn. Exp. - 81.07 62.56 84.65 77.77 55.54 50.72 34.34 51.13 29.63 22.26 % Of Sales - 14.20% 11.51% 15.02% 15.04% 11.72% 12.99% 6.47% 8.61% 7.47% 6.29% Miscellaneous Exp. - 9.58 11.87 6.16 6.67 4.58 5.12 6.09 7.27 4.50 22.26 % Of Sales - 1.68% 2.18% 1.09% 1.29% 0.97% 1.31% 1.15% 1.22% 1.13% 1.18% EBITDA 80.19 46.29 36.94 16.42 -11.41 -12.97 -68.46 30.26 103.76 89.05 112.24 EBITDA Margin 11.64% 8.11% 6.79% 2.91% -2.21% -2.74% -17.53% 5.70% 17.48% 22.45% 31.74% Other Income 12.61 12.25 14.39 6.77 5.85 9.21 10.46 6.33 6.00 5.56 13.88 Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14 4.86 Depreciation 14.55 14.74 15.83 17.43 15.28 10.12 12.28 7.34 8.81 6.08 6.88 PBT 78.24 43.80 35.50 5.76 -20.84 -13.89 -70.27 29.25 100.95 88.39 114.38 Tax 30.41 17.89 15.45 0.50 0.00 0.51 19.26 9.49 36.82 30.77 40.54 Tax Rate 38.87% 40.84% 43.52% 8.68% 0.00% 0.00% -27.41% 32.44% 36.47% 34.81% 35.44% PAT 47.83 25.91 20.05 5.26 -20.84 -0.51 -89.53 19.77 64.13 57.62 73.84 PAT before Minority Interest 47.83 25.91 20.05 5.26 -20.84 -0.51 -89.53 19.77 64.13 57.62 73.84 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.94% 4.54% 3.69% 0.93% -4.03% -0.11% -22.93% 3.72% 10.81% 14.53% 20.88% PAT Growth 260.17% 29.23% 281.18% 125.24% -3986.27% 99.43% -552.86% -69.17% 11.30% -21.97% Unadjusted EPS 19.14 10.40 8.00 2.10 -8.34 -0.20 -35.81 7.91 25.65 23.05 29.53

Description

TTM

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Dec 09

Dec 08

Net Sales

688.72

571.00

543.71

563.73

517.07

473.97

390.42

530.82

593.52

396.69

353.63

Net Sales Growth

27.98%

5.02%

-3.55%

9.02%

9.09%

21.40%

-26.45%

-10.56%

49.62%

12.18%

Cost Of Goods Sold

215.05

178.78

171.18

194.81

194.23

155.08

146.54

162.20

159.00

107.77

84.87

Gross Profit

473.67

392.22

372.53

368.93

322.84

318.90

243.88

368.63

434.52

288.92

268.76

GP Margin

68.78%

68.69%

68.52%

65.44%

62.44%

67.28%

62.47%

69.45%

73.21%

72.83%

76.00%

Total Expenditure

608.53

524.71

506.77

547.31

528.48

486.94

458.88

500.56

489.76

307.64

241.39

Power & Fuel Cost

8.30

7.68

7.43

8.51

8.69

5.82

3.10

3.31

1.96

2.25

% Of Sales

1.45%

1.41%

1.32%

1.65%

1.83%

1.49%

0.58%

0.56%

0.49%

0.64%

Employee Cost

153.53

162.04

169.35

159.84

160.46

148.46

161.91

150.50

81.33

60.80

% Of Sales

26.89%

29.80%

30.04%

30.91%

33.85%

38.03%

30.50%

25.36%

20.50%

17.19%

Manufacturing Exp.

50.10

36.40

25.82

17.69

35.93

38.26

38.29

29.68

26.91

33.46

% Of Sales

8.77%

6.69%

4.58%

3.42%

7.58%

9.80%

7.21%

5.00%

6.78%

9.46%

General & Admin Exp.

43.35

55.04

59.10

63.77

66.68

63.95

94.63

88.87

55.55

33.57

% Of Sales

7.59%

10.12%

10.48%

12.33%

14.07%

16.38%

17.83%

14.97%

14.00%

9.49%

Selling & Distn. Exp.

81.07

62.56

84.65

77.77

55.54

50.72

34.34

51.13

29.63

22.26

% Of Sales

14.20%

11.51%

15.02%

15.04%

11.72%

12.99%

6.47%

8.61%

7.47%

6.29%

Miscellaneous Exp.

9.58

11.87

6.16

6.67

4.58

5.12

6.09

7.27

4.50

22.26

% Of Sales

1.68%

2.18%

1.09%

1.29%

0.97%

1.31%

1.15%

1.22%

1.13%

1.18%

EBITDA

80.19

46.29

36.94

16.42

-11.41

-12.97

-68.46

30.26

103.76

89.05

112.24

EBITDA Margin

11.64%

8.11%

6.79%

2.91%

-2.21%

-2.74%

-17.53%

5.70%

17.48%

22.45%

31.74%

Other Income

12.61

12.25

14.39

6.77

5.85

9.21

10.46

6.33

6.00

5.56

13.88

Interest

0.00

0.14

4.86

Depreciation

14.55

14.74

15.83

17.43

15.28

10.12

12.28

7.34

8.81

6.08

6.88

PBT

78.24

43.80

35.50

5.76

-20.84

-13.89

-70.27

29.25

100.95

88.39

114.38

Tax

30.41

17.89

15.45

0.50

0.00

0.51

19.26

9.49

36.82

30.77

40.54

Tax Rate

38.87%

40.84%

43.52%

8.68%

0.00%

-27.41%

32.44%

36.47%

34.81%

35.44%

PAT

47.83

25.91

20.05

5.26

-20.84

-0.51

-89.53

19.77

64.13

57.62

73.84

PAT before Minority Interest

47.83

25.91

20.05

5.26

-20.84

-0.51

-89.53

19.77

64.13

57.62

73.84

Minority Interest

0.00

PAT Margin

6.94%

4.54%

3.69%

0.93%

-4.03%

-0.11%

-22.93%

3.72%

10.81%

14.53%

20.88%

PAT Growth

260.17%

29.23%

281.18%

125.24%

-3986.27%

99.43%

-552.86%

-69.17%

11.30%

-21.97%

Unadjusted EPS

19.14

10.40

8.00

2.10

-8.34

-0.20

-35.81

7.91

25.65

23.05

29.53

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Dec 09 Dec 08
Shareholder's Funds 246.93 222.87 156.01 150.76 171.60 99.75 189.29 179.69 144.52 116.15 Share Capital 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 5.00 Total Reserves 239.85 216.22 151.01 145.76 166.60 94.75 184.29 174.69 139.52 111.15 Non-Current Liabilities 109.73 88.68 38.96 1.02 0.49 0.49 -17.22 -3.92 -2.94 60.13 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 62.50 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 142.28 128.90 37.70 0.00 0.00 0.00 0.00 3.10 0.00 0.00 Current Liabilities 218.67 202.05 234.05 259.82 243.50 205.86 155.08 125.37 89.35 110.11 Trade Payables 95.34 87.66 94.63 111.27 109.87 90.67 20.91 14.38 12.16 7.43 Other Current Liabilities 71.27 69.84 121.08 111.60 96.50 77.21 67.46 62.71 34.04 40.07 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 52.06 44.55 18.33 36.95 37.13 37.98 66.71 48.29 43.15 62.60 Total Liabilities 575.33 513.60 429.02 411.60 415.59 306.10 327.15 301.14 230.93 286.39 Net Block 75.46 86.84 97.36 100.99 94.22 24.54 31.69 27.45 30.02 30.36 Gross Block 105.85 102.57 203.76 191.44 169.75 98.64 95.42 84.52 82.80 81.07 Accumulated Depreciation 30.39 15.73 106.40 90.46 75.53 74.11 63.73 57.06 52.79 50.70 Non Current Assets 242.69 250.34 161.95 148.33 140.96 141.29 132.56 81.59 30.34 30.46 Capital Work in Progress 3.57 4.81 6.31 12.21 9.31 73.70 58.49 23.93 0.31 0.09 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 Long Term Loans & Adv. 163.39 158.27 57.68 34.55 37.06 34.73 39.98 26.91 0.00 0.00 Other Non Current Assets 0.27 0.42 0.61 0.59 0.37 8.32 2.40 3.29 0.00 0.00 Current Assets 332.64 263.26 267.07 263.26 274.62 164.81 194.59 219.55 200.59 255.93 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 113.15 57.71 76.73 86.13 95.76 85.37 75.10 57.20 35.20 34.01 Sundry Debtors 54.63 43.00 83.14 42.77 52.93 27.96 32.31 43.71 68.21 50.14 Cash & Bank 125.92 115.58 76.83 25.08 89.07 18.47 53.22 85.39 68.24 143.80 Other Current Assets 38.94 23.54 10.15 1.81 36.87 33.01 33.96 33.25 28.95 27.98 Short Term Loans & Adv. 28.45 23.43 20.22 107.46 32.33 20.33 23.06 28.33 26.27 19.93 Net Current Assets 113.97 61.21 33.03 3.44 31.12 -41.05 39.50 94.18 111.24 145.82 Total Assets 575.33 513.60 429.02 411.59 415.58 306.10 327.15 301.14 230.93 286.39

Description

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Dec 09

Dec 08

Shareholder's Funds

246.93

222.87

156.01

150.76

171.60

99.75

189.29

179.69

144.52

116.15

Share Capital

5.00

Total Reserves

239.85

216.22

151.01

145.76

166.60

94.75

184.29

174.69

139.52

111.15

Non-Current Liabilities

109.73

88.68

38.96

1.02

0.49

-17.22

-3.92

-2.94

60.13

Secured Loans

0.00

62.50

Unsecured Loans

0.00

Long Term Provisions

142.28

128.90

37.70

0.00

3.10

0.00

Current Liabilities

218.67

202.05

234.05

259.82

243.50

205.86

155.08

125.37

89.35

110.11

Trade Payables

95.34

87.66

94.63

111.27

109.87

90.67

20.91

14.38

12.16

7.43

Other Current Liabilities

71.27

69.84

121.08

111.60

96.50

77.21

67.46

62.71

34.04

40.07

Short Term Borrowings

0.00

Short Term Provisions

52.06

44.55

18.33

36.95

37.13

37.98

66.71

48.29

43.15

62.60

Total Liabilities

575.33

513.60

429.02

411.60

415.59

306.10

327.15

301.14

230.93

286.39

Net Block

75.46

86.84

97.36

100.99

94.22

24.54

31.69

27.45

30.02

30.36

Gross Block

105.85

102.57

203.76

191.44

169.75

98.64

95.42

84.52

82.80

81.07

Accumulated Depreciation

30.39

15.73

106.40

90.46

75.53

74.11

63.73

57.06

52.79

50.70

Non Current Assets

242.69

250.34

161.95

148.33

140.96

141.29

132.56

81.59

30.34

30.46

Capital Work in Progress

3.57

4.81

6.31

12.21

9.31

73.70

58.49

23.93

0.31

0.09

Non Current Investment

0.00

0.01

Long Term Loans & Adv.

163.39

158.27

57.68

34.55

37.06

34.73

39.98

26.91

0.00

Other Non Current Assets

0.27

0.42

0.61

0.59

0.37

8.32

2.40

3.29

0.00

Current Assets

332.64

263.26

267.07

263.26

274.62

164.81

194.59

219.55

200.59

255.93

Current Investments

0.00

Inventories

113.15

57.71

76.73

86.13

95.76

85.37

75.10

57.20

35.20

34.01

Sundry Debtors

54.63

43.00

83.14

42.77

52.93

27.96

32.31

43.71

68.21

50.14

Cash & Bank

125.92

115.58

76.83

25.08

89.07

18.47

53.22

85.39

68.24

143.80

Other Current Assets

38.94

23.54

10.15

1.81

36.87

33.01

33.96

33.25

28.95

27.98

Short Term Loans & Adv.

28.45

23.43

20.22

107.46

32.33

20.33

23.06

28.33

26.27

19.93

Net Current Assets

113.97

61.21

33.03

3.44

31.12

-41.05

39.50

94.18

111.24

145.82

Total Assets

575.33

513.60

429.02

411.59

415.58

306.10

327.15

301.14

230.93

286.39

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Dec 09 Dec 08
Cash From Operating Activity 8.79 38.10 56.99 -45.70 -0.81 -6.04 38.73 64.50 32.57 81.65 PBT 43.80 35.50 5.76 -20.84 0.00 -70.27 29.25 100.95 88.39 114.38 Adjustment 3.39 14.61 12.11 8.58 -10.85 2.97 1.79 3.07 3.18 1.48 Changes in Working Capital -34.25 -0.24 42.09 -32.58 17.66 61.06 38.58 5.16 -23.39 -2.20 Cash after chg. in Working capital 12.94 49.87 59.97 -44.83 6.81 -6.24 69.62 109.18 68.18 113.66 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.61 Tax Paid -4.15 -11.77 -2.98 -0.87 -7.62 0.20 -30.89 -44.68 -35.61 -32.62 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -9.36 0.25 -3.61 -18.64 -14.57 -15.62 -33.68 -27.69 2.19 5.26 Net Fixed Assets -2.04 102.69 -6.42 -24.59 -6.72 -18.43 -45.46 -25.34 -1.95 1.82 Net Investments 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 Others -7.32 -102.44 2.81 5.95 -7.86 2.81 11.78 -2.35 4.14 3.44 Cash from Financing Activity 0.00 0.00 -0.51 0.00 86.22 -10.33 -29.07 -29.09 -110.88 -54.14 Net Cash Inflow / Outflow -0.57 38.35 52.87 -64.34 70.84 -31.98 -24.03 7.72 -76.12 32.77 Opening Cash & Equivalents 114.55 76.20 23.33 87.68 16.83 48.81 72.84 65.12 143.80 111.04 Closing Cash & Equivalent 113.98 114.55 76.20 23.33 87.68 16.83 48.81 72.84 67.68 143.80

Description

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Dec 09

Dec 08

Cash From Operating Activity

8.79

38.10

56.99

-45.70

-0.81

-6.04

38.73

64.50

32.57

81.65

PBT

43.80

35.50

5.76

-20.84

0.00

-70.27

29.25

100.95

88.39

114.38

Adjustment

3.39

14.61

12.11

8.58

-10.85

2.97

1.79

3.07

3.18

1.48

Changes in Working Capital

-34.25

-0.24

42.09

-32.58

17.66

61.06

38.58

5.16

-23.39

-2.20

Cash after chg. in Working capital

12.94

49.87

59.97

-44.83

6.81

-6.24

69.62

109.18

68.18

113.66

Interest Paid

0.00

0.61

Tax Paid

-4.15

-11.77

-2.98

-0.87

-7.62

0.20

-30.89

-44.68

-35.61

-32.62

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

Cash From Investing Activity

-9.36

0.25

-3.61

-18.64

-14.57

-15.62

-33.68

-27.69

2.19

5.26

Net Fixed Assets

-2.04

102.69

-6.42

-24.59

-6.72

-18.43

-45.46

-25.34

-1.95

1.82

Net Investments

0.00

0.01

0.00

Others

-7.32

-102.44

2.81

5.95

-7.86

2.81

11.78

-2.35

4.14

3.44

Cash from Financing Activity

0.00

-0.51

0.00

86.22

-10.33

-29.07

-29.09

-110.88

-54.14

Net Cash Inflow / Outflow

-0.57

38.35

52.87

-64.34

70.84

-31.98

-24.03

7.72

-76.12

32.77

Opening Cash & Equivalents

114.55

76.20

23.33

87.68

16.83

48.81

72.84

65.12

143.80

111.04

Closing Cash & Equivalent

113.98

114.55

76.20

23.33

87.68

16.83

48.81

72.84

67.68

143.80

Financial Ratios

Standalone

Description Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11 Dec 09 Dec 08
Book Value (Rs.) 97.94 88.49 62.41 60.30 68.64 39.90 75.71 71.88 57.81 46.46 ROA 4.76% 4.25% 1.25% -5.04% -0.14% -28.28% 6.29% 24.11% 22.28% 21.29% ROE 11.12% 10.63% 3.43% -12.93% -0.38% -61.95% 10.71% 39.56% 44.21% 53.61% ROCE 18.65% 18.74% 3.76% -12.93% 0.00% -48.62% 15.86% 62.27% 54.79% 70.56% Fixed Asset Turnover 5.49 3.58 2.88 2.91 3.61 4.11 6.05 7.24 4.94 4.55 Receivable days 31.15 41.96 40.32 33.27 30.50 27.61 25.51 33.74 53.35 47.59 Inventory Days 54.51 44.72 52.15 63.23 68.29 73.50 44.39 27.86 31.20 28.30 Payable days 61.99 75.53 75.14 85.64 81.76 50.01 15.35 11.64 13.99 9.55 Cash Conversion Cycle 23.67 11.15 17.33 10.86 17.03 51.10 54.54 49.96 70.55 66.34 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.54 Interest Cover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 646.26 24.52

Description

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Dec 09

Dec 08

Book Value (Rs.)

97.94

88.49

62.41

60.30

68.64

39.90

75.71

71.88

57.81

46.46

ROA

4.76%

4.25%

1.25%

-5.04%

-0.14%

-28.28%

6.29%

24.11%

22.28%

21.29%

ROE

11.12%

10.63%

3.43%

-12.93%

-0.38%

-61.95%

10.71%

39.56%

44.21%

53.61%

ROCE

18.65%

18.74%

3.76%

-12.93%

0.00%

-48.62%

15.86%

62.27%

54.79%

70.56%

Fixed Asset Turnover

5.49

3.58

2.88

2.91

3.61

4.11

6.05

7.24

4.94

4.55

Receivable days

31.15

41.96

40.32

33.27

30.50

27.61

25.51

33.74

53.35

47.59

Inventory Days

54.51

44.72

52.15

63.23

68.29

73.50

44.39

27.86

31.20

28.30

Payable days

61.99

75.53

75.14

85.64

81.76

50.01

15.35

11.64

13.99

9.55

Cash Conversion Cycle

23.67

11.15

17.33

10.86

17.03

51.10

54.54

49.96

70.55

66.34

Total Debt/Equity

0.00

0.54

Interest Cover

0.00

646.26

24.52

Astrazeneca Pharma India Ltd.

Pharmaceuticals & Drugs

BSE: 506820 | NSE: ASTRAZEN

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Astrazeneca Pharma India Ltd.

Pharmaceuticals & Drugs

BSE: 506820 | NSE: ASTRAZEN

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update